TotalMarketCap

Wave Life Sciences

WVENasdaq SingaporeHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$638.036 M

$3.24 -10.63%

Close of 6 Nov 2026

As of 6 Nov 2026, Wave Life Sciences (WVE) has a market capitalization of $638.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$42.7M

#2765 by revenue

Earnings

-$204.4M

Loss-making

Shares outstanding

197,228,968

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #165Ironwood PharmaceuticalsIRWD$657.7M
  2. #166Sagimet BiosciencesSGMT$642.6M
  3. #167Wave Life SciencesWVE$638.0M
  4. #168Zevra TherapeuticsZVRA$626.6M
  5. #169Evotec SEEVO$626.1M

What if Wave Life Sciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$143,167.98

Per share 44,256× higher

Bitcoin $1.53T

$7,746.57

Per share 2,395× higher

Apple $5.02T

$25,431.27

Per share 7,861× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Wave Life Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.